MedTrace Logo

Lycopene or Green Tea for Men at Risk of Prostate Cancer

NCT01105338 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2018-01-23

No results posted yet for this study

Summary

RATIONALE: Lycopene and green tea may stop or delay the development of recurrent prostate cancer in patients has been treated for prostate cancer. It is not yet known whether lycopene or green tea may be more effective in preventing prostate cancer.

PURPOSE: This randomized phase II trial is studying lycopene to see how well it works compared with green tea in preventing prostate cancer in patients previously enrolled in the ProtecT trial

Conditions

Interventions

BEHAVIORAL

Green tea drink

Green tea drink

DIETARY_SUPPLEMENT

green tea capsules

green tea capsules

OTHER

Green tea placebo capsules

Green tea placebo capsules

DIETARY_SUPPLEMENT

Lycopene capsules

Lycopene capsules

OTHER

Lycopene placebo capsules

Lycopene placebo capsules

OTHER

Tomato rich diet

Tomato rich diet

Sponsors & Collaborators

  • University of Bristol

    lead OTHER

Principal Investigators

  • Athene Lane, PhD · University of Bristol

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
FACTORIAL

Eligibility

Min Age
50 Years
Max Age
69 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2010-08-31
Completion
2010-08-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01105338 on ClinicalTrials.gov